Brian Betensky, MD
Clinical Cardiac Electrophysiology · Sarasota, FLNPI 1851553481
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $259,634 of the $411,563 with a category attached, or 63.1%. 31 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 27.8% of the total. 2025 is the largest year on record at $119,183, 2.9 times the $41,701 reported in 2019. Among clinical cardiac electrophysiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 971 payments — averaging $423.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$114K
- Boston Scientific$93K
- Elutia, Inc.$74K
- Medical Device Business Services, Inc.$57K
- Abbott$35K
- Biosense Webster, Inc.$27K
- plus $11K from 25 others
Across 46 payments — averaging $4450.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$205K
What the payments were for
- Consulting fees$130,62432%
- Speaking & faculty fees$259,63463%
- Travel & lodging$4,6211%
- Food & beverage$16,6154%
- Education$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 233 | $114,476 |
| Boston Scientific | 163 | $93,178 |
| Elutia, Inc. | 131 | $74,247 |
| Medical Device Business Services, Inc. | 18 | $56,700 |
| Abbott | 67 | $35,437 |
| Biosense Webster, Inc. | 98 | $26,752 |
| Cardiva Medical, Inc. | 7 | $5,597 |
| Medtronic(2 entities) | 90 | $1,408 |
| Johnson & Johnson | 12 | $1,315 |
| Novartis | 37 | $524 |
| Sanofi-aventis U.S. LLC | 17 | $326 |
| Merck | 17 | $309 |
| Amgen | 25 | $284 |
| Pfizer | 15 | $244 |
| Acutus Medical, Inc. | 5 | $104 |
| Esperion Therapeutics, Inc. | 5 | $100 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Boehringer Ingelheim | 4 | $71 |
| Cvrx, Inc. | 3 | $65 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| AstraZeneca | 2 | $35 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $31 |
| Cordis US CORP. | 2 | $30 |
| Amarin Pharma, Inc. | 2 | $30 |
| Philips North America LLC | 1 | $28 |
| Heartflow, Inc. | 1 | $26 |
| Novo Nordisk | 1 | $16 |
| Kestra Medical Technology Services, Inc. | 1 | $13 |
| Biotronik Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$110,097
- Carto 3$81,314
- ECM Patch,Pouch$72,478
- GENERAL EP$59,688
- GENERAL - THERAPIES$17,281
- GENERAL BRADY$14,100
- Ensite Cardiac Mapping System$12,686
- Endurity Pacemaker$7,711
- Cardiva VASCADE MVP VVCS 6-12F$5,375
- GALLANT$5,250
- Assurity Pacemaker$2,889
- AVEIR$2,245
- ALLURE$1,181
- XARELTO$1,160
- Anthem CRT Pacemaker$749
- Allure Quadra RF CRT Pacemaker$749
- Accent Pacemaker$642
- Allure CRT Pacemaker$525
- Quadra Assura CRT Defibrillator$182
- GENERAL TACHY$134
How this compares
$411,563 in reported general payments places this provider in the 95th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 626 | $781,748 |
| FarxigaDapagliflozin Propanediol | 65 | $74,926 |
| XareltoRivaroxaban | 63 | $68,460 |
| EntrestoSacubitril/Valsartan | 51 | $61,107 |
| MultaqDronedarone Hcl | 29 | $50,791 |
| Repatha SureclickEvolocumab | 36 | $24,532 |
| Dofetilide | 25 | $11,313 |
| Metoprolol Succinate | 534 | $8,039 |
| Flecainide Acetate | 136 | $5,979 |
| Mexiletine Hcl | 43 | $4,192 |
| SotalolSotalol Hcl | 180 | $3,825 |
| Amiodarone Hcl | 59 | $3,443 |
| Ezetimibe | 49 | $1,667 |
| Atorvastatin Calcium | 142 | $1,427 |
| Metoprolol Tartrate | 193 | $1,138 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $244 | $781,748626 claims |
| AstraZenecaFarxiga | $35 | $74,92665 claims |
| Johnson & JohnsonXarelto | $1,315 | $68,46063 claims |
| NovartisEntresto | $524 | $61,10751 claims |
| Sanofi-aventis U.S. LLCMultaq | $326 | $50,79129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Sarasota
- Antonio MorettaSarasota$312K
- Dilip MathewSarasota$209K
- Likhitesh JaikumarSarasota$63K
- Robert EckartSarasota$58K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.